7 Overstated
Amentoflavone reduces anxiety.
"Amentoflavone actually lowers anxiety." (said at 0:00:40)
Evidence that amentoflavone reduces anxiety is limited entirely to preclinical animal models; there are no published human clinical trials evaluating its anxiolytic effects. In rodent behavioral assays (such as the elevated plus maze, hole-board test, light/dark box test, and stress-induced hyperthermia models), isolated amentoflavone demonstrated anxiolytic-like activity that appears to involve ionotropic GABA(A) receptor signaling. However, pharmacokinetic studies suggest that amentoflavone crosses the blood-brain barrier poorly in vivo, and whether these preclinical behavioral findings translate to anxiety reduction in humans remains unestablished.
- partial: Effects of St. John's wort extract and single constituents on stress-induced hyperthermia … (Planta medica 2006) · cited 24x in the literature
"From the biflavonoids in SJW, only amentoflavone decreased SIH-induced hyperthermia in a dosage of 0.1 mg/kg. In conclusion, using open field stress as a psychological stressor to induce hyperthermia in mice we were able to detect putative anxiolytic effects of SJW extract and single consituents." (abstract, results, passage verified)
pubmedfull study (doi) - context: St. John's wort components and the brain: uptake, concentrations reached and the mechanism… (Current drug metabolism 2009) · cited 30x in the literature
"the (scant) data so far suggest that the acylphloroglucinol hyperforin, the flavonol quercetin and its glycosylated forms and their metabolites, the biflavones amentoflavone and its I3,II8-analog biapigenin and the naphthodianthrones hypericin and pseudohypericin pass the blood-brain barrier poorly in animals." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Antidepressant and anxiolytic effects of amentoflavone isolated from Cnestis ferruginea in… (Pharmacology, biochemistry, and behavior 2012) · cited 115x in the literature
"CF extract and CF-2 significantly (p<0.05) attenuated anxiety by increasing the number of head-dips in the hole-board test, the time spent on the open arms in the EPM, and the exploration of the light chamber in the light/dark test. Pretreatment with flumazenil (3mg/kg, i.p., ionotropic GABA receptor antagonist) 15min before oral administration of amentoflavone (25mg/kg) significantly reduced the time spent in the open arms in EPM." (abstract, results, passage verified)
pubmedfull study (doi)
Clinical data shows that eating approximately one cup of strawberries per day over a couple of weeks lowers depression, improves cognition, and specifically improves memory.
"Now, what's interesting is the clinical data also shows that people who eat strawberries, about a cup of strawberries a day over the course of a couple of weeks, will also change mental state. It'll actually lower depression, improve cognition, specifically improve memory." (said at 0:18:47)
A 2023 randomized controlled trial evaluated daily strawberry supplementation (whole-fruit strawberry powder equivalent to one cup of fresh fruit) in overweight, middle-aged adults with insulin resistance and subjective cognitive decline. The study reported a modest reduction in depressive symptoms (p = 0.04) and reduced memory interference (p = 0.02) relative to placebo. However, the trial lasted 12 weeks (three months), not 'a couple of weeks', was conducted in a specific small cohort with pre-existing metabolic and cognitive risk factors, and represents preliminary evidence rather than definitive clinical proof for the general population.
- partial: Early Intervention in Cognitive Aging with Strawberry Supplementation. (Nutrients 2023) · cited 22x in the literature
"In this controlled trial, we enrolled overweight middle-aged men and women with insulin resistance and subjective cognitive decline and performed a 12-week intervention with daily administration of whole-fruit strawberry powder... We observed diminished memory interference ( p = 0.02; Cohen's f = 0.45) and a reduction of depressive symptoms ( p = 0.04; Cohen's f = 0.39) for the strawberry-treated participants; benefits consistent with improved executive ability." (abstract, results, passage verified)
pubmedfull study (doi)
Bifidobacterium longum 1714 improves the quality of deep sleep.
"You know what one patient of mine said, you know, "Dr. Hyman, I took this probiotic and I was just looking it up, and it was a specific strain, Bifidobacterium longum 1714, improves the quality of deep sleep."" (said at 0:25:43)
Randomized controlled trials evaluating Bifidobacterium longum 1714 have shown modest, transient improvements in subjective overall sleep quality (assessed via the Pittsburgh Sleep Quality Index) or sleep duration during periods of academic stress. However, no clinical evidence demonstrates that this probiotic strain specifically enhances 'deep sleep' (slow-wave sleep). In an 8-week trial in 89 adults with impaired sleep, B. longum 1714 led to subjective improvements at week 4 that were no longer significantly different from placebo by week 8, and objective actigraphy measurements showed no significant differences.
- partial: Improvements in sleep indices during exam stress due to consumption of a Bifidobacterium l… (Brain, behavior, & immunity - health 2021) · cited 69x in the literature
"While overall sleep quality and duration of sleep improved significantly in the probiotic treated group during exam stress compared with the placebo treated group, B. longum 1714, similar to placebo treatment, showed no efficacy in improving measures of working memory, visual memory, sustained attention or perception." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Bifidobacterium longum 1714 improves sleep quality and aspects of well-being in healthy ad… (Scientific reports 2024) · cited 50x in the literature
"While PSQI global score improved in both groups, B. longum 1714 significantly improved the PSQI component of sleep quality (p < 0.05) and daytime dysfunction due to sleepiness (p < 0.05) after 4 weeks and social functioning (p < 0.05) and energy/vitality (p < 0.05) after 8 weeks, compared to placebo. No significant effect on actigraphy measures were observed." (abstract, results, passage verified)
pubmedfull study (doi)
Ursolic acid improves cerebral blood flow and improves cognition.
"And so too is the ursolic acid, which improves blood flow, which improves brain blood flow, which improves cognition." (said at 0:20:30)
The claim states that ursolic acid improves cerebral blood flow and thereby improves cognition. While preclinical animal studies (e.g., in rodent models of Alzheimer's disease or diabetes) suggest that ursolic acid can exert neuroprotective effects and improve performance on memory tests, no clinical trials or published scientific records demonstrate that ursolic acid increases cerebral blood flow or enhances cognition in humans. Stating these effects definitively as human cognitive and vascular benefits overstates the existing preliminary animal and in vitro literature.
- partial: Rosmarinic acid and ursolic acid alleviate deficits in cognition, synaptic regulation and … (Phytomedicine : international journal of phytotherapy and phytopharmacology 2021) · cited 93x in the literature
"The results show a protective effect by rosmarinic acid and ursolic acid in reversing the deficits in spatial and recognition memory as well as changes in anxiety induced by Aβ 1-42." (abstract, results, passage verified)
pubmedfull study (doi) - context: Neuroprotective properties of Betulin, Betulinic acid, and Ursolic acid as triterpenoids d… (Nutritional neuroscience 2024) · cited 54x in the literature
"Betulin (B), betulinic acid (BA), and ursolic acid (UA) are pentacyclic triterpenoid compounds with a variety of biological activities, including antioxidative, neuroprotective and anti-inflammatory properties. This review focuses on the therapeutic efficacy and probable molecular mechanisms of triterpenoids in damage prevention to neurons and restoring cognition in neurodegenerative diseases." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Dark chocolate contains anandamide, which activates the brain's endocannabinoid system.
"cacao has all these polyphenols in it, like proanthocyanidins and others, including anandamide. All right. And what do anandamides do when you eat them? They not only lower inflammation, but they stimulate the endocannabinoid system in your brain." (said at 0:47:14)
Cocoa and chocolate contain trace amounts of anandamide and related N-acylethanolamines that act as lipid cannabinoid mimics or inhibitors of anandamide breakdown. However, claiming that eating anandamide in dark chocolate stimulates the endocannabinoid system in the brain overstates the evidence: orally ingested lipid amides are rapidly metabolized in the gastrointestinal tract and liver, and there is no strong evidence that dietary trace quantities cross the blood-brain barrier to directly activate central cannabinoid receptors. Furthermore, anandamide is an N-acylethanolamine lipid rather than a polyphenol.
Barley contains beta-glucan, a dietary fiber that stimulates blood vessel growth (angiogenesis) and nerve growth.
"Barley can also be beneficial. Barley has beta-glucan which is also found in mushrooms, culinary mushrooms as well as medicinal mushrooms. It's a kind of dietary fiber. They grow blood vessels and it can stimulate nerve growth as well." (said at 0:55:02)
The claim that barley contains beta-glucan which stimulates blood vessel growth (angiogenesis) and nerve growth overstates the available scientific evidence. Preclinical in vitro and animal research demonstrates that barley-derived (1,3)-β-D-glucan can stimulate angiogenic responses and vascular formation under oxidative stress conditions in endothelial cells (HUVECs) and zebrafish embryos (PMID: 25388628). However, this effect has been demonstrated only in cell and animal models using isolated purified extracts, not human dietary consumption of barley. Furthermore, evidence direct to barley beta-glucan stimulating nerve growth in humans or animal models is lacking in published literature.
Quantitative brain MRI and fMRI data in veterans with traumatic brain injury and PTSD demonstrate measurable brain repair following ibogaine treatment.
"cuz there's data that improves brain health and the veterans who've had brain drama—I mean, brain drama, brain trauma, traumatic brain injury and brain drama, actually PTSD—actually show that their brains repair looking at functional MRIs or quantitative MRIs." (said at 0:55:45)
A prospective open-label observational study of 30 male military veterans with traumatic brain injury (TBI) and comorbid psychiatric symptoms (including PTSD) evaluated magnesium-ibogaine treatment using arterial spin labeling (ASL) and resting-state functional MRI (fMRI). The study observed increases in regional cerebral blood flow (rCBF) in cortical, limbic, and striatal subregions, as well as alterations in functional connectivity that correlated with symptom improvement. However, framing these neuroimaging changes as proof that the brain 'repairs' overstates the findings: functional neuroimaging measures blood flow and network connectivity rather than direct structural tissue repair or regeneration. Additionally, the study was an uncontrolled, open-label trial, precluding definitive conclusions about treatment causality or biological tissue repair.
2 Needs context
Studies at the University of Massachusetts showed that pesticides sprayed on apples penetrate 20% deep into the skin of the apple.
"So again, it turns out studies at UMass, University of Massachusetts, have studied if you take regular pesticides, spray them on an apple like in a conventional farm, basically the pesticides will penetrate 20% deep into the skin of the apple." (said at 0:20:11)
A 2017 study conducted at the University of Massachusetts Amherst (Yang et al.) evaluated the penetration of pesticides into apples and the efficacy of various washing agents. The researchers found that after 24 hours of exposure, 20% of the applied amount of the systemic fungicide thiabendazole (and 4.4% of the non-systemic insecticide phosmet) had penetrated into the apples. The speaker slightly mischaracterizes the metric by describing the 20% figure as a depth percentage ('penetrate 20% deep into the skin') rather than the fraction of applied pesticide quantity that entered the fruit tissue.
Feeding Lactobacillus reuteri as a probiotic doubled the rate of wound healing in a study by prompting VEGF gene expression and blood vessel growth.
"So we actually did a research study where we were actually looking at whether or not feeding Lactobacillus reuteri as a probiotic would speed up wound healing. And indeed it doubled the rate of wound healing, and it did it from the gut by increasing the gene expression, turning on the genetic machinery for a protein called vascular endothelial growth factor, VEGF, just to prompt new blood vessels to grow just to be able to heal the wound." (said at 0:23:26)
In a controlled animal study in mice (PMID 24205344), oral administration of Lactobacillus reuteri in drinking water accelerated skin wound closure to occur in half the time of control animals (effectively doubling the rate of wound healing). The mechanism was shown to involve vagus nerve signaling, neuropeptide oxytocin up-regulation, and enhanced immune regulatory T-cell responses. Evidence is currently limited to preclinical rodent models, meaning translation to clinical wound healing rates in humans remains unestablished.
18 Supported by research
The New England Journal of Medicine published an article on the 'dark matter' of nutrition describing 139,000 distinct compounds in food from phytochemicals that regulate human biology.
"And there was an interesting article, I don't know if you saw, in the New England Journal of Medicine about the dark matter of nutrition. It was about the 139,000 different compounds in food that regulate our biology that are from phytochemicals." (said at 0:01:33)
A review article by researchers in network medicine was published in The New England Journal of Medicine ('Chemical Complexity of Food and Implications for Therapeutics', 2025), exploring the 'dark matter' of nutrition. This line of research, also detailed in reviews such as 'Decoding the Foodome' (2024), explores the estimated ~139,000 untracked biochemical compounds—predominantly phytochemicals and secondary metabolites—present in the human diet that extend far beyond standard nutritional databases and interact with human biological targets.
In a randomized clinical study, adults taking a brain-available form of magnesium reported improvements in sleep quality and daytime functioning compared to placebo.
"Now, in one randomized clinical study, adults who took a brain-available form of magnesium reported improvements in sleep quality and daytime functioning compared to placebo." (said at 0:13:12)
A double-blind, randomized, placebo-controlled clinical trial evaluated magnesium L-threonate (a form of magnesium known for crossing the blood-brain barrier) in 80 adults aged 35–55 with self-reported sleep problems. Compared with placebo, participants taking 1 g/day of magnesium L-threonate for 21 days demonstrated significant improvements in subjective measures of sleep quality, daytime productivity, alertness, and mood, as well as objective wearable sleep metrics.
In vitro studies show that applying ellagic acid or microbiome short-chain fatty acids to cultured inflammatory cells suppresses inflammatory activation.
"How do we know this? Because if you actually grow inflammatory cells in a petri dish in a tissue culture and you put ellagic acid in there, they will stop having a riot. They'll calm down. If you actually put the short-chain fatty acids of the gut microbiome in the same dish, they'll also calm down." (said at 0:18:31)
In vitro experimental models support the speaker's claim that both ellagic acid and gut microbiome-derived short-chain fatty acids (such as butyrate) suppress inflammatory activation in cultured immune cells. Studies using lipopolysaccharide (LPS)-stimulated macrophage cell lines (e.g., RAW 264.7) demonstrate that ellagic acid significantly attenuates pro-inflammatory cytokines such as TNF-α, IL-6, and prostaglandin E2. Similarly, applying short-chain fatty acids like butyrate downregulates inflammatory signaling pathways (such as NF-κB) and suppresses the production of pro-inflammatory cytokines and chemokines. Because this evidence is derived entirely from pre-clinical in vitro cell culture models, certainty is graded as very low.
- supports: Quantitative Analysis and In vitro Anti-inflammatory Effects of Gallic Acid, Ellagic Acid,… (Pharmacognosy magazine 2016) · cited 58x in the literature
"All of the marker compounds exhibited inhibitory effects on prostaglandin E2 production in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages, with no cytotoxicity. Particularly, ellagic acid significantly inhibited production of the proinflammatory cytokines tumor necrosis factor alpha and interleukin-6 in LPS-treated RAW 264.7 cells." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Proof-of-Principle Study Suggesting Potential Anti-Inflammatory Activity of Butyrate and P… (International journal of molecular sciences 2022) · cited 24x in the literature
"We report here that butyrate was effective in reducing the lipopolysaccharide (LPS)-induced expression of IL6 and chemokine (C-X-C motif) ligand 2 (CXCL2) in the RAW 264.7 and primary macrophages." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Sodium butyrate alleviates colitis by inhibiting mitochondrial ROS mediated macrophage pyr… (Biochimica et biophysica acta. Molecular basis of disease 2025) · cited 9x in the literature
"Additionally, NaB demonstrated in vitro inhibition of RAW264.7 inflammation cytokines induced by LPS, along with suppression of the ERK and NF-κB signaling pathway activation." (abstract, results, passage verified)
pubmedfull study (doi)
Pulverized, non-viable Lactobacillus reuteri administered in drinking water to animals stimulates the brain to release oxytocin.
"So think about like a naval weapon, the sound weapon, and you can beam it at the Lactobacillus reuteri, pulverize it into a gajillion pieces. All right? You feed it to an experimental system to animals, putting it in their drinking water. And guess what? The dead pulverized bacteria will also make the brain release oxytocin." (said at 0:24:58)
Animal research supports the claim. In mouse models, oral dietary administration of a sterile lysate (non-viable, broken-down preparation) of Lactobacillus reuteri significantly increased oxytocin-producing cells in the paraventricular nucleus (PVN) of the hypothalamus and raised systemic oxytocin levels, demonstrating that bacterial viability is not required for oxytocin upregulation. Because evidence is limited to animal models, certainty is very low.
- supports: Microbial lysate upregulates host oxytocin. (Brain, behavior, and immunity 2017) · cited 154x in the literature
"Oxytocin-producing cells were found to be increased in the caudal paraventricular nucleus [PVN] of the hypothalamus after feeding of a sterile lysed preparation of L. reuteri, coincident with lowered blood levels of stress hormone corticosterone and more rapid epidermal closure, in mouse models. We conclude that microbe viability is not essential for regulating host oxytocin levels." (abstract, results, passage verified)
pubmedfull study (doi)
Pomegranate, green tea, and cranberry promote the growth and abundance of Akkermansia in the gut.
"pomegranate and green tea and cranberry have super beneficial effects on a keystone species called Akkermansia that protects the lining of the gut and prevents leaky gut and reduces inflammation" (said at 0:21:40)
Published research demonstrates that polyphenols from pomegranate, green tea, and cranberry increase the abundance of Akkermansia muciniphila in the gut. Systematic review data of human clinical trials supports pomegranate extract in increasing A. muciniphila levels, while evidence for green tea and cranberry extracts comes primarily from preclinical rodent models showing significant increases in A. muciniphila alongside improved intestinal barrier integrity and reduced systemic inflammation.
- supports: A polyphenol-rich cranberry extract reverses insulin resistance and hepatic steatosis inde… (Molecular metabolism 2017) · cited 186x in the literature
"The gut microbiota of HFHS + CE mice was characterized by lower Firmicutes to Bacteroidetes ratio and a drastic expansion of Akkermansia muciniphila and, to a lesser extent, of Barnesiella spp, as compared to HFHS controls." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Dietary Factors and Modulation of Bacteria Strains of Akkermansia muciniphila and Faecalib… (Nutrients 2019) · cited 196x in the literature
"A caloric restriction diet and supplementation with pomegranate extract, resveratrol, polydextrose, yeast fermentate, sodium butyrate, and inulin increased the abundance of A. muciniphila" (abstract, results, passage verified)
pubmedfull study (doi) - supports: Green Tea Encourages Growth of Akkermansia muciniphila . (Journal of medicinal food 2020) · cited 34x in the literature
"Interestingly, GT administration significantly encouraged the growth of Akkermansia muciniphila ( Akkermansia ), a beneficial microorganism to relieve obesity and related metabolic disorders." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Cranberry polyphenols and agave agavins impact gut immune response and microbiota composit… (Frontiers in immunology 2022) · cited 77x in the literature
"Oral supplementation with CP selectively and robustly (five-fold) increases the relative abundance of Akkermansia muciniphila , a beneficial bacteria associated with metabolic health." (abstract, results, passage verified)
pubmedfull study (doi)
The human small intestine is approximately 22 feet long.
"Small intestines is a long snaky tube like your garden hose, 22 ft." (said at 0:05:05)
The statement that the human small intestine is approximately 22 feet long aligns well with published anatomical and surgical measurements. In living adults, total small bowel length shows natural inter-individual variation, with systematic reviews and large surgical cohorts reporting mean lengths typically between 506 cm and 795 cm (approximately 16.6 to 26.1 feet), placing 22 feet (~6.7 meters or 670 cm) directly within the standard anatomical range.
Artificial sweeteners can be up to a thousand times sweeter than regular sugar.
"if you're, for example, having artificial sweeteners, which are a thousand times sweeter than regular sugar" (said at 0:35:20)
High-intensity artificial and non-nutritive sweeteners range widely in their sweetening potency relative to table sugar (sucrose). Common artificial sweeteners such as aspartame and acesulfame potassium are roughly 200 times sweeter than sucrose, saccharin is 300–500 times sweeter, sucralose is about 600 times sweeter, and newer approved high-potency sweeteners like neotame and advantame range from 7,000 to over 20,000 times sweeter. The statement that artificial sweeteners can be hundreds to thousands of times sweeter than regular sugar is well-supported by established food science and sensory evaluations.
- supports: Effects of Sweeteners on the Gut Microbiota: A Review of Experimental Studies and Clinical… (Advances in nutrition (Bethesda, Md.) 2019) · cited 434x in the literature
"Sweeteners that are frequently several hundred thousand times sweeter than sucrose are being consumed as sugar substitutes. Although nonnutritive sweeteners (NNSs) are considered safe and well tolerated, their effects on glucose intolerance, the activation of sweet taste receptors, and alterations to the composition of the intestinal microbiota are controversial. This review critically discusses the evidence supporting the effects of NNSs, both synthetic sweeteners (acesulfame K, aspartame, cyclamate, saccharin, neotame, advantame, and sucralose)" (abstract, passage verified)
pubmedfull study (doi) - supports: Beyond Sugar: A Holistic Review of Sweeteners and Their Role in Modern Nutrition. (Foods (Basel, Switzerland) 2025) · cited 36x in the literature
"This work categorizes sweeteners into synthetic options (such as aspartame, sucralose, saccharin) and naturally occurring ones (such as stevia, monk fruit, and polyols like sorbitol, xylitol, erythritol), focusing on physico-chemical characteristics, relative sweetness (ranging from 100 to 220,000 times sweeter than sucrose), and glycemic index" (abstract, passage verified)
pubmedfull study (doi)
Research shows chimpanzees instinctively select and chew specific polyphenol-rich plants to heal wounds when injured.
"I don't know if you saw the research that looked at chimpanzees knowing inherently when they're injured that they'll pick specific plants to chew on them that will give them the bioactives of polyphenols from certain plants in order to be able to heal their wounds." (said at 0:36:53)
Observational research in wild chimpanzees (and other great apes) supports the claim that injured individuals selectively consume or process specific plants with potent bioactive properties to aid healing. A 2024 zoopharmacognosy study in the Budongo Forest documented injured chimpanzees seeking out and consuming rarely eaten plant species, such as the fern Christella parasitica and Khaya anthotheca bark/resin. In vitro pharmacological assays showed these specific extracts had potent anti-inflammatory (COX-2 inhibition) and antibacterial activities. Similar behavior was also documented in 2024 in a wild Sumatran orangutan, which chewed a medicinal liana (Fibraurea tinctoria) and applied its bioactive-rich juice directly to a facial wound. Certainty is rated as low due to the observational nature of field ethology combined with in vitro screening.
- context: Active self-treatment of a facial wound with a biologically active plant by a male Sumatra… (Scientific reports 2024) · cited 39x in the literature
"Three days after the injury he selectively ripped off leaves of a liana with the common name Akar Kuning (Fibraurea tinctoria), chewed on them, and then repeatedly applied the resulting juice onto the facial wound... Previous analyses of plant chemical compounds show the presence of furanoditerpenoids and protoberberine alkaloids, which are known to have antibacterial, anti-inflammatory, anti-fungal, antioxidant, and other biological activities of relevance to wound healing." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Pharmacological and behavioral investigation of putative self-medicative plants in Budongo… (PloS one 2024) · cited 32x in the literature
"In total, we selected plant parts from 13 species (nine trees and four herbaceous plants)... In the anti-inflammatory COX-2 inhibition library screen, 17 out of 51 tested extracts (33%) showed ≥50% COX-2 inhibition... The K. anthotheca bark and resin methanol-water extract showed the most potent effects (IC50: 0.55 μg/mL), followed by the fern Christella parasitica methanol-water extract (IC50: 0.81 μg/mL). This fern species was consumed by an injured individual, a feeding behavior documented only once before in this population." (abstract, results)
pubmedfull study (doi)
Brain inflammation is a common biological denominator observed across conditions such as schizophrenia, autism, major depression, and bipolar disorder.
"regardless of what mental health condition that you're talking about, everything from schizophrenia to autism to major depression, bipolar disorder, you know, so far what's been looked at as a common denominator of these syndromes is actually inflammation in the brain." (said at 0:37:59)
Published cross-disorder transcriptomic and neuroimaging research supports the statement that brain inflammation and neuroimmune dysregulation act as common, transdiagnostic features across major psychiatric and neurodevelopmental conditions, including schizophrenia, autism spectrum disorder, major depressive disorder, and bipolar disorder. Large-scale postmortem human brain transcriptome analyses demonstrate shared expression changes in innate immune-related genes across these four conditions. Furthermore, molecular neuroimaging and clinical reviews identify glial cell immune alterations and neuroinflammatory markers as shared pathophysiological denominators across these diagnoses.
- supports: The role of inflammation and microglial activation in the pathophysiology of psychiatric d… (Neuroscience 2015) · cited 592x in the literature
"This review will highlight the role of inflammation in the pathophysiology of psychiatric disorders, such as MDD, BD, schizophrenia, and autism." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Neuroimmune transcriptome changes in patient brains of psychiatric and neurological disord… (Molecular psychiatry 2023) · cited 70x in the literature
"In this study, 1275 IRGs were curated and their expression changes investigated in 2467 postmortem brains of controls and patients with six major brain disorders, including schizophrenia (SCZ), bipolar disorder (BD), autism spectrum disorder (ASD), major depressive disorder (MDD), Alzheimer's disease (AD), and Parkinson's disease (PD). There were 865 IRGs present across all microarray and RNA-seq datasets. More than 60% of the IRGs had significantly altered expression in at least one of the six disorders. The differentially expressed immune-related genes (dIRGs) shared across disorders were mainly related to innate immunity." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Neuroimaging evidence of mitochondrial dysfunction and inflammation in psychiatric disorde… (Psychoradiology 2026)
"Based on imaging evidence across different psychiatric disorders and cohorts, this review summarizes three transdiagnostic imaging features: impaired mitochondrial energy metabolism, alterations in glial cell immune status, and white matter microstructural alterations associated with neuroinflammation." (abstract, results, passage verified)
pubmedfull study (doi)
Studies have investigated using TNF-alpha blockers as a treatment for depression.
"I even read a study that was showing they were interested in using TNF-alpha blockers for depression" (said at 0:38:43)
Multiple clinical trials have investigated the use of tumor necrosis factor (TNF) antagonists, such as infliximab, for the treatment of major depressive disorder and bipolar depression, particularly in patients with elevated baseline inflammatory biomarkers.
- supports: A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treat… (JAMA psychiatry 2013) · cited 1606x in the literature
"To determine whether inhibition of the inflammatory cytokine tumor necrosis factor (TNF) reduces depressive symptoms in patients with treatment-resistant depression and whether an increase in baseline plasma inflammatory biomarkers, including high-sensitivity C-reactive protein (hs-CRP), TNF, and its soluble receptors, predicts treatment response." (abstract, objective, passage verified)
pubmedfull study (doi) - supports: Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II … (JAMA psychiatry 2019) · cited 197x in the literature
"To assess the antidepressant efficacy of adjunctive infliximab, a monoclonal antibody targeting tumor necrosis factor, in adults with bipolar I and bipolar II depression and inflammatory conditions." (abstract, objective, passage verified)
pubmedfull study (doi)
Polyphenols found in fruits and vegetables lower biological inflammation.
"all those polyphenols and fruits and vegetables that you would eat can actually lower inflammation." (said at 0:39:30)
Multiple systematic reviews and meta-analyses of randomized controlled trials demonstrate that dietary polyphenols—such as those found in fruits, vegetables, and botanical sources—significantly reduce circulating biomarkers of inflammation, including C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-α).
- supports: Effects of resveratrol on the anthropometric indices and inflammatory markers: an umbrella… (European journal of nutrition 2024) · cited 10x in the literature
"The results from 19 meta-analyses investigating 81 unique randomized controlled trials with 4088 participants revealed that resveratrol supplementation reduced the body mass index (ES = -0.119, 95% CI (-0.192, -0.047), p = 0.001), waist circumference (ES = -0.405, 95% CI [-0.664, -0.147], p = 0.002), serum levels of C-reactive protein (ES = -0.390, 95% CI [-0.474, -0.306], p < 0.001), and tumor necrosis factor-α (ES = -0.455, 95% CI [-0.592, -0.318], p < 0.001) in comparison to the control group." (abstract, results)
pubmedfull study (doi) - supports: The effect of pomegranate juice supplementation on C-reactive protein levels: GRADE-assess… (Phytotherapy research : PTR 2024) · cited 3x in the literature
"Meta-analysis showed that PJ supplementation led to a significant decrease in CRP levels compared to control groups (WMD: -2.55 mg/L; 95%CI: -3.44 to -1.66; p < 0.001)." (abstract, results, passage verified)
pubmedfull study (doi)
Psychological stress causes physical inflammation in the body.
"Stress causes inflammation. Most of us have a little bit more stress than we want in our lives. And so we're always a little bit inflamed" (said at 0:39:45)
Extensive meta-analytic evidence from experimental human laboratory studies demonstrates that acute psychological stress induces rapid, significant increases in circulating pro-inflammatory cytokines, including interleukin-6 (IL-6), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α). Furthermore, randomized controlled trials show that reducing psychological distress through psychological interventions significantly reduces systemic inflammatory markers such as C-reactive protein.
- supports: The effects of acute psychological stress on circulating inflammatory factors in humans: a… (Brain, behavior, and immunity 2007) · cited 1276x in the literature
"Results showed robust effects for increased levels of circulating IL-6 (r=0.19, p=0.001) and IL-1beta (r=0.58, p<0.001) following acute stress, and marginal effects for CRP (r=0.12, p=0.088)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The effects of acute psychological stress on circulating and stimulated inflammatory marke… (Brain, behavior, and immunity 2017) · cited 683x in the literature
"Results showed significant stress-related increases in circulating interleukin (IL)-1β (d=0.66, p<0.001), IL-6 (d=0.35, p<0.001), IL-10 (d=0.69, p<0.001), and tumor necrosis factor(TNF)-α (d=0.28, p<0.001)" (abstract, results, passage verified)
pubmedfull study (doi) - supports: Effects of psychological interventions on systemic levels of inflammatory biomarkers in hu… (Brain, behavior, and immunity 2018) · cited 61x in the literature
"The overall combined effect size from pre to post psychological intervention on pro-inflammatory biomarker levels was statistically significant, showing an attenuating effect, although of a small magnitude (s' g = 0.15, p = .008, CI [0.04-0.26])." (abstract, results, passage verified)
pubmedfull study (doi)
Abdominal fat cells produce inflammatory adipocytokines that cross into or affect the brain.
"Those cells in your belly are not just holding up your pants. They're little factories of inflammation creating adipocytokines, which are inflammatory molecules from the fat cells that go to your brain and affect everything." (said at 0:42:08)
Visceral adipose tissue (abdominal fat) acts as an active endocrine and immune organ. When enlarged or dysfunctional, it secretes pro-inflammatory cytokines and adipokines/adipocytokines (such as TNF-alpha, IL-6, and leptin). These circulating molecules can cross or disrupt the blood-brain barrier, triggering neuroinflammation, microglial activation, and synaptic dysfunction that influence central nervous system health and cognitive function.
- supports: Adipose Tissue and Central Nervous System Crosstalk: Roles in Pain and Cognitive Dysfuncti… (Biomedicines 2025) · cited 5x in the literature
"We articulate a framework where, in pathological states such as obesity, dysfunctional adipose tissue releases a milieu of factors-including adipokines, lipids, and extracellular vesicles-that propagate peripheral and central neuroinflammation, disrupt blood-brain barrier integrity, and impair synaptic plasticity." (abstract, passage verified)
pubmedfull study (doi) - supports: Adipose tissue as a systemic modulator of brain aging: mechanistic links between metabolis… (Brain research 2026) · cited 2x in the literature
"Chronic low-grade inflammation, impaired insulin signaling, dyslipidemia, adipokine imbalance and senescence-associated secretory activity originating in adipose tissue act on the aging brain by promoting microglial dysfunction, cerebrovascular impairment, blood-brain barrier (BBB) disruption and synaptic vulnerability." (abstract, passage verified)
pubmedfull study (doi)
Truffles contain anandamide.
"Anandamide in truffles and chocolate." (said at 0:48:55)
Black truffles (specifically Tuber melanosporum) have been confirmed to contain the endocannabinoid anandamide (N-arachidonoylethanolamine) alongside its key metabolic synthesis and degradation enzymes. Liquid chromatography-mass spectrometry (LC-MS) analyses confirmed the presence and accumulation of anandamide across different maturation stages of the truffle fruiting bodies.
Research shows infrared saunas improve circulation, mitochondrial activity, and repair processes.
"And the research suggests that infrared may help support circulation, improve mitochondrial activity and the body's own natural repair processes, all of which play a role in how we age." (said at 0:50:54)
Research supports the statement that infrared exposure can improve vascular circulation, mitochondrial activity, and cellular repair processes. Far-infrared thermal exposure (such as far-infrared dry sauna or Waon therapy) has been demonstrated in clinical trials to enhance endothelial function, flow-mediated dilation, and peripheral circulation. Additionally, near-infrared light exposure (photobiomodulation) acts directly on mitochondrial cytochrome c oxidase to stimulate ATP synthesis, modulate cellular energetics, and promote downstream tissue repair and regeneration pathways.
- supports: Repeated thermal therapy improves impaired vascular endothelial function in patients with … (Journal of the American College of Cardiology 2001) · cited 276x in the literature
"Two weeks of sauna therapy significantly improved %FMD in the risk group (4.0 +/- 1.7% to 5.8 +/- 1.3%, p < 0.001)... Repeated sauna treatment improves impaired vascular endothelial function in the setting of coronary risk factors, suggesting a therapeutic role for sauna treatment in patients with risk factors for atherosclerosis." (abstract, results)
pubmedfull study (doi) - supports: Waon therapy mobilizes CD34+ cells and improves peripheral arterial disease. (Journal of cardiology 2010) · cited 60x in the literature
"Waon therapy mobilized circulating endothelial progenitor cells and improved limb ischemia in patients with PAD. Waon therapy is a highly promising therapy for patients with PAD." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Mechanisms of action and clinical research progress of photobiomodulation. (Journal of photochemistry and photobiology. B, Biology 2026)
"The core mechanism of PBM relies on photon absorption at specific wavelengths by mitochondrial cytochrome c oxidase. By activating the mitochondrial electron transport chain, enhancing ATP synthesis, and regulating reactive oxygen species signaling, PBM mediates multiple downstream signaling pathways, including PI3K/Akt, MAPK, and NF-κB... summarizing the molecular mechanisms and research progress of PBM across five major areas: tissue repair and regeneration, anti-inflammatory and immunomodulatory effects..." (abstract, results, passage verified)
pubmedfull study (doi)
Psilocybin lowers the activity of the brain's default mode network and activates brain-derived neurotrophic factor (BDNF) to increase neural connectivity and neurogenesis.
"And I don't think it just works through its ability to reduce your anxiety through lowering the function of certain areas like your default mode network which is your ego and your anxiety or amygdala. But I think it has other effects and some has these neurotropic effects using activation of things like BDNF or brain-derived neurotrophic factor which increases the connectivity in the neurogenesis in the brain." (said at 0:53:45)
The claim accurately reflects neuroimaging and preclinical neurobiological research. Human fMRI studies show that psilocybin acutely reduces functional coupling and metabolic activity within core hubs of the default mode network (mPFC and PCC). Furthermore, in vitro human neuronal models and rodent studies demonstrate that psilocybin (and its active metabolite psilocin) upregulates brain-derived neurotrophic factor (BDNF), enhances TrkB signaling, stimulates neurogenesis (e.g., in the hippocampus), and promotes structural synaptic plasticity and connectivity.
- supports: Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. (Proceedings of the National Academy of Sciences of the United States of America 2012) · cited 1203x in the literature
"Psilocybin caused a significant decrease in the positive coupling between the mPFC and PCC. These results strongly imply that the subjective effects of psychedelic drugs are caused by decreased activity and connectivity in the brain's key connector hubs" (abstract, results, passage verified)
pubmedfull study (doi) - supports: Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through … (Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2026) · cited 4x in the literature
"At the molecular level, psilocybin normalized mature BDNF (mBDNF), increased TrkB, and restored downstream AKT signaling in the prefrontal cortex of Fmr1- Δ exon 8 rats, pathways strongly linked to synaptic plasticity and cognitive function." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons. (eLife 2026) · cited 5x in the literature
"Psilocin provoked a 5-HT2A-R-mediated augmentation of BDNF abundance. Transcriptomic profiling identified gene expression signatures priming neurons to neuroplasticity. On a morphological level, psilocin induced enhanced neuronal complexity and increased expression of synaptic proteins" (abstract, results, passage verified)
pubmedfull study (doi) - supports: Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats… (Progress in neuro-psychopharmacology & biological psychiatry 2026) · cited 1x in the literature
"Psilocybin induced hippocampal neurogenesis as evidenced by increasing the number of BrdU-positive cells (an exogenous marker of cell proliferation and survival), DCX-positive cells (a marker of immature neurons), and Ki-67-positive cells" (abstract, results, passage verified)
pubmedfull study (doi)
AI applied to high-resolution retinal imaging can detect early signs of Alzheimer's disease and kidney dysfunction.
"And they can tell Alzheimer's, kidney function. I mean it's crazy the stuff that they're able to detect and stuff that an ophthalmologist wouldn't be able to detect because the AI can start to see these things." (said at 1:02:23)
Published systematic reviews, meta-analyses, and observational cohort studies support the claim that artificial intelligence (AI) models applied to retinal imaging can detect signs of both Alzheimer's disease and chronic kidney dysfunction. Meta-analyses of diagnostic accuracy show that AI algorithms analyzing retinal fundus photographs and optical coherence tomography achieve an AUC of 0.72 for detecting Alzheimer's disease and an AUC of 0.86 for detecting chronic kidney disease.
- supports: Deep-learning models for the detection and incidence prediction of chronic kidney disease … (Nature biomedical engineering 2021) · cited 325x in the literature
"Here we show that deep-learning models can be used to identify chronic kidney disease and type 2 diabetes solely from fundus images or in combination with clinical metadata (age, sex, height, weight, body-mass index and blood pressure) with areas under the receiver operating characteristic curve of 0.85-0.93." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Performance of deep learning for detection of chronic kidney disease from retinal fundus p… (European journal of ophthalmology 2024) · cited 7x in the literature
"Deep learning based on retinal fundus photographs has the ability to detect CKD" (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Retinal imaging and artificial intelligence: A systematic review and meta-analysis of diag… (Photodiagnosis and photodynamic therapy 2025) · cited 10x in the literature
"Artificial intelligence (AI)-driven analysis of retinal images holds promise for noninvasive, early detection of neurodegenerative disorders." (abstract, background, passage verified)
pubmedfull study (doi)
The ketogenic diet is being researched and explored as a clinical intervention for psychiatric disorders and metabolic conditions, including schizophrenia, bipolar disorder, obsessive-compulsive disorder (OCD), depression, cancer, and diabetes.
"There are more extreme versions like a ketogenic diet, which is now being explored for schizophrenia and bipolar disease and OCD and cancer and severe depression and diabetes." (said at 0:45:03)
The speaker accurately states that the ketogenic diet is being investigated and explored across these conditions. Established clinical applications and clinical trials exist for type 2 diabetes and metabolic disorders, and emerging research (including pilot clinical trials and mechanistic reviews) is actively exploring ketogenic metabolic therapy for psychiatric conditions such as schizophrenia, bipolar disorder, and major depressive disorder, as well as adjunctive therapy in oncology.
- supports: Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophren… (Psychiatry research 2024) · cited 142x in the literature
"The ketogenic diet (KD, also known as metabolic therapy) has been successful in the treatment of obesity, type 2 diabetes, and epilepsy. More recently, this treatment has shown promise in the treatment of psychiatric illness. We conducted a 4-month pilot study to investigate the effects of a KD on individuals with schizophrenia or bipolar disorder with existing metabolic abnormalities." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The Potential Effects of the Ketogenic Diet in the Prevention and Co-Treatment of Stress, … (Nutrients 2024) · cited 27x in the literature
"Just in recent years, an increasing amount of animal and clinical human surveys have focused on investigating the possible impacts of the KD in the prevention and co-treatment of depression, anxiety, stress, schizophrenia, and bipolar disorder." (abstract, results, passage verified)
pubmedfull study (doi)
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.